Stockreport

BRIEF-Egalet Corp's Phase 3 Study Of Egalet-002 In Patients With Moderate-To-Severe Chronic Low Back Pain Meets Primary Endpoint [Reuters]

EGALET CORP COMMON  (EGLT) 
Last egalet corp common earnings: 8/8 06:02 am Check Earnings Report
US:NASDAQ Investor Relations: egalet.com/about-egalet/company-overview
PDF BRIEF-Egalet Corp's Phase 3 Study Of Egalet-002 In Patients With Moderate-To-Severe Chronic Low Back Pain Meets Primary Endpoint? | Reuters Reuters Staff 1 Min Read Nov [Read more]